Delivery Order SPE2DB22D2206-SPE2DB25FJG38
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count packages) valued at $3,508.43. This contract utilizes a firm fixed-price structure with an ultimate completion date of September 26, 2025, and was awarded on a competitive basis without any set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Janumet XR 100-1,000 mg tablets (90-count units) with a ceiling value of $5,326.55. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The order is due for completion by November 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) with a ceiling value of $4,698.53. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive procurement. The contract will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 12, 2025. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Janumet XR 50-1,000 mg tablets (60-count units) with a ceiling value of $19,258.50. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a competitive delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Janumet XR 100-1,000 mg tablets (90-count units) with a ceiling value of $1,522.98. The contract is classified as a firm fixed-price delivery order with an ultimate completion date of October 30, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Janumet XR 50-1,000 mg tablets (60-count units) with a ceiling value of $3,444.40. This is a firm fixed price delivery order under a non-set-aside competitive procurement. The order is set for ultimate completion by October 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract action, this...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count) with a ceiling value of $1,746.19. This firm fixed price delivery order, which is not set-aside and represents a competitively awarded contract, is scheduled for completion by July 25, 2025. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Janumet XR 50–1,000 mg tablets (180-count units) with a ceiling value of $4,031.11. This competitively awarded, non-set-aside delivery order is structured as a firm fixed-price contract with an ultimate completion date of November 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Janumet XR 50-1,000 mg tablets (180-count units) valued at $3,328.77. This firm fixed-price delivery order is set to be completed by July 31, 2025, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a non-competitive delivery against AmerisourceBergen's larger indefinite delivery contract with DLA. This delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of Janumet XR 50-1,000 mg tablets in a quantity of 180 units. This non-set-aside contract, valued at approximately $35,000, represents a firm fixed-price delivery order with an ultimate completion date of June 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJG38Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Janumet XR 50-1,000 mg tablets in quantities of 180 units. This is a firm fixed-price delivery order with a ceiling value of $4,910.44 and an ultimate completion date of August 7, 2025. The contract utilizes no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. This award represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor supporting federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of pharmaceutical products and medical supplies, including brand-name and generic medications, vaccines, and specialized medical devices. The Janumet XR delivery order aligns with the company's established role as a primary pharmaceutical vendor through the DLA's global pharmaceutical support program, which supplies military healthcare programs worldwide with diabetes and other therapeutic medications.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.9k | 8/6/25 |